A detailed history of Caitong International Asset Management Co., LTD transactions in Innoviva, Inc. stock. As of the latest transaction made, Caitong International Asset Management Co., LTD holds 3,068 shares of INVA stock, worth $56,236. This represents 0.04% of its overall portfolio holdings.

Number of Shares
3,068
Holding current value
$56,236
% of portfolio
0.04%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 13, 2025

BUY
$17.21 - $18.98 $52,800 - $58,230
3,068 New
3,068 $55.6 Million

Others Institutions Holding INVA

About Innoviva, Inc.


  • Ticker INVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,706,000
  • Market Cap $1.28B
  • Description
  • Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...
More about INVA
Track This Portfolio

Track Caitong International Asset Management Co., LTD Portfolio

Follow Caitong International Asset Management Co., LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caitong International Asset Management Co., LTD, based on Form 13F filings with the SEC.

News

Stay updated on Caitong International Asset Management Co., LTD with notifications on news.